MPO
Showing 1 - 25 of 292
COPD, Healthy Older Adults Trial in Umeå (Supramaximal High-Intensity Interval Training at 60% of MPO6, Moderate-Intensity
Completed
- COPD
- Healthy Older Adults
- Supramaximal High-Intensity Interval Training at 60% of MPO6
- +2 more
-
Umeå, SwedenUmeå University
May 15, 2023
COPD (COPD) Trial (AZD4831, Placebo)
Not yet recruiting
- Chronic Obstructive Pulmonary Disease (COPD)
- AZD4831
- Placebo
- (no location specified)
Aug 5, 2022
pH, HNE and MPO Levels in Detecting Wound Infection Proof of
Not yet recruiting
- Wound Infection
- Wound Heal
- (no location specified)
Jul 27, 2021
Evaluation of Anti-neutrophil Cytoplasm Antibodies Test
Not yet recruiting
- Immunological Testing in Small-vessel Vasculitis
- Indirect immunofluorescence (IIF) , myeloperoxidase antibody(MPO)- and anti-proteinase 3 (PR3-) ANCA immunoassays
-
Miki, Kagawa, JapanKagawa univeristy
Jan 19, 2021
Study Protocol for PROFEMUR® Gladiator Cemented Femoral Stems
Terminated
- Joint Disease
- total hip arthroplasty implant
- (no location specified)
Dec 16, 2022
Inflammatory Response, Cardiac Disease Trial (Colchicine 0.5 MG, Placebo)
Not yet recruiting
- Inflammatory Response
- Cardiac Disease
- Colchicine 0.5 MG
- Placebo
- (no location specified)
Nov 1, 2023
Study Protocol for CONSERVE® Press-Fit Femoral Components
Active, not recruiting
- Joint Disease
- Primary hip resurfacing device
-
Ottawa, Ontario, CanadaOttawa Hospital
Apr 13, 2022
Standardized Flow Cytometric Assay of Peripheral Blood
Active, not recruiting
- Myelodysplastic Syndromes
- Diagnostic Test: Flow cytometry analysis of neutrophil myeloperoxidase expression
-
Grenoble, FranceChu Grenoble Alpes
Oct 29, 2021
Security Efficacy COVID-19 Vaccination
Completed
- Autoimmune State
- SARS-CoV-2 Infection
- Blood sampling
-
Milan, ItalyIstituto Auxologico Italiano IRCCS
Feb 23, 2023
Late Anthracycline Induced Cardiotoxicity- Childhood Cancer
Recruiting
- Anthracycline Induced Cardiotoxicity
-
Belfast, United KingdomBelfast Health and Social Care Trust
Sep 7, 2022
Malnutrition Trial in Dhaka (L- carnitine oral solution, Placebo)
Recruiting
- Malnutrition
- L- carnitine oral solution
- Placebo
-
Dhaka, BangladeshDhaka Hospital; International Centre for Diarrhoeal Disease Rese
Jan 3, 2023
Cryptosporidiosis and Enteropathogens in Bangladesh
Active, not recruiting
- Cryptosporidiosis
-
Dhaka, BangladeshThe International Centre for Diarrhoeal Disease Research, Bangla
Dec 1, 2022
Cognitive Decline, Mild Cognitive Impairment, Aging Trial in New Taipei City, Tainan, Taoyuan (Chicken extract supplement,
Completed
- Cognitive Decline
- +2 more
- Chicken extract supplement
- +2 more
-
New Taipei City, Taiwan
- +2 more
Nov 18, 2022
Ruling Out Myelodysplastic Syndromes: Protocol forDiagnostic
Recruiting
- Myelodysplastic Syndromes
- Flow cytometric analysis of neutrophil myeloperoxidase expression
-
Clermont-Ferrand, France
- +5 more
Mar 24, 2022
Thrombosis in Myeloproliferative Neoplasms
Completed
- Myeloproliferative Neoplasm
- 2 additional tubes of blood
-
Angers, France
- +23 more
Aug 17, 2022
NET Activation in Congenital Heart Disease and Heart Failure
Not yet recruiting
- Congenital Heart Disease
- +2 more
- Biological markers of myocardial fibrosis
-
Paris, France
- +1 more
Feb 21, 2022
Interstitial Lung Disease Associated
Completed
- Interstitial Lung Disease
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Aug 17, 2023
Netosis During COVID-19, Under Treatment With
Active, not recruiting
- Covid19
-
Paris, France
- +1 more
Mar 30, 2022
Multiple System Atrophy (MSA) Trial in Morrisville (BHV3241, verdiperstat)
No longer available
- Multiple System Atrophy (MSA)
- BHV3241, verdiperstat
-
Morrisville, North CarolinaPPD
Oct 4, 2022
EVOLUTION® Total Knee Arthroplasty System With Cruciate
Active, not recruiting
- Joint Disease
- Total Knee Arthroplasty (EVOLUTION®)
-
Morton Grove, Illinois
- +4 more
Oct 5, 2021
Obesity, Metabolic Syndrome, Metabolic Disorder Trial in Seville (Oral lipid emulsions)
Not yet recruiting
- Obesity
- +4 more
- Oral lipid emulsions
-
Seville, SpainUniversity of Seville
Sep 19, 2023
Healthy Infants Trial in China (a2 Platinum® stage 1 infant formula, Conventional, A1 and A2 ß-casein containing stage 1 infant
Completed
- Healthy Infants
- a2 Platinum® stage 1 infant formula
- Conventional, A1 and A2 β-casein containing stage 1 infant formula
-
Nanjing, Jiangsu, China
- +4 more
Nov 2, 2022
Study Protocol for PROFEMUR® TL Modular Femoral Stems
Enrolling by invitation
- Joint Disease
- total hip arthroplasty implant
-
Ottawa, Ontario, CanadaOttawa Hospital
Apr 5, 2022
Study Protocol for DYNASTY® BioFoam® Acetabular Components
Active, not recruiting
- Joint Disease
- total hip arthroplasty implant
-
Ottawa, Ontario, CanadaOttawa Hospital
Apr 5, 2022